- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1534-6269
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Neuroblastoma Heterogeneity, Plasticity, and Emerging Therapies ; day:1 ; month:4 ; year:2022 ; pages:1-10
Current oncology reports ; (1.4.2022), 1-10
- Creator
-
Lundberg, Kristina Ihrmark
Treis, Diana
Johnsen, John Inge
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s11912-022-01270-8
- URN
-
urn:nbn:de:101:1-2022062020354200673858
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:37 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lundberg, Kristina Ihrmark
- Treis, Diana
- Johnsen, John Inge
- SpringerLink (Online service)
Other Objects (12)
Heterogeneity of metastogenic neuroblastoma cells
Neuroblastoma and its Target Therapies: A Medicinal Chemistry Review
MYCN, proliferative heterogeneity and treatment response ¡n neuroblastoma
MYCN, proliferative heterogeneity and treatment response in neuroblastoma
Emerging therapies in neurorehabilitation
Emerging therapies for PBC
Signaling, cancer cell plasticity, and intratumor heterogeneity
Neuroblastoma with high ASPM reveals pronounced heterogeneity and poor prognosis
Emerging therapies for severe asthma
Emerging Therapies for Rheumatoid Arthritis
Emerging therapies for breast cancer
CXCR4 expression heterogeneity in neuroblastoma cells due to ligand-independent regulation
Heterogeneity of metastogenic neuroblastoma cells
Neuroblastoma and its Target Therapies: A Medicinal Chemistry Review
MYCN, proliferative heterogeneity and treatment response ¡n neuroblastoma
MYCN, proliferative heterogeneity and treatment response in neuroblastoma
Emerging therapies in neurorehabilitation
Emerging therapies for PBC
Signaling, cancer cell plasticity, and intratumor heterogeneity
Neuroblastoma with high ASPM reveals pronounced heterogeneity and poor prognosis
Emerging therapies for severe asthma
Emerging Therapies for Rheumatoid Arthritis
Emerging therapies for breast cancer
CXCR4 expression heterogeneity in neuroblastoma cells due to ligand-independent regulation
Heterogeneity of metastogenic neuroblastoma cells
Neuroblastoma and its Target Therapies: A Medicinal Chemistry Review
MYCN, proliferative heterogeneity and treatment response ¡n neuroblastoma
MYCN, proliferative heterogeneity and treatment response in neuroblastoma
Emerging therapies in neurorehabilitation
Emerging therapies for PBC
Signaling, cancer cell plasticity, and intratumor heterogeneity
Neuroblastoma with high ASPM reveals pronounced heterogeneity and poor prognosis
Emerging therapies for severe asthma
Emerging Therapies for Rheumatoid Arthritis
Emerging therapies for breast cancer